Upgrade Your Browser
We no longer support this version of your browser.
We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.
Return to the course you were viewing
You'll hear more about bromocriptine for type 2 diabetes.
A new low-dose form of bromocriptine called Cycloset will be marketed for diabetes in the U.S. later this year.
This is a surprise. We usually think of bromocriptine as a dopamine agonist for Parkinson's or to decrease prolactin levels.
Pharmacist's Letter Canada includes:
Already a subscriber? Log in
Volume pricing available. Get quote